BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 15838186)

  • 1. Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta database.
    Saletu B; Prause W; Anderer P; Mandl M; Aigner M; Mikova O; Saletu-Zyhlarz GM
    Neuropsychobiology; 2005; 51(3):148-63. PubMed ID: 15838186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the pharmacotherapy of sleep bruxism: placebo-controlled polysomnographic and psychometric studies with clonazepam.
    Saletu A; Parapatics S; Saletu B; Anderer P; Prause W; Putz H; Adelbauer J; Saletu-Zyhlarz GM
    Neuropsychobiology; 2005; 51(4):214-25. PubMed ID: 15915004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone.
    Saletu-Zyhlarz GM; Abu-Bakr MH; Anderer P; Gruber G; Mandl M; Strobl R; Gollner D; Prause W; Saletu B
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):249-60. PubMed ID: 11817501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone.
    Saletu-Zyhlarz GM; Abu-Bakr MH; Anderer P; Semler B; Decker K; Parapatics S; Tschida U; Winkler A; Saletu B
    Neuropsychobiology; 2001; 44(3):139-49. PubMed ID: 11586054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
    Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
    Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder.
    Saletu-Zyhlarz G; Anderer P; Brandstätter N; Dantendorfer K; Gruber G; Mandl M; Ritter K; Zoghlami A; Saletu B
    Neuropsychobiology; 2000; 41(3):139-48. PubMed ID: 10754428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
    Saletu M; Anderer P; Saletu-Zyhlarz G; Hauer C; Saletu B
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An E-health solution for automatic sleep classification according to Rechtschaffen and Kales: validation study of the Somnolyzer 24 x 7 utilizing the Siesta database.
    Anderer P; Gruber G; Parapatics S; Woertz M; Miazhynskaia T; Klosch G; Saletu B; Zeitlhofer J; Barbanoj MJ; Danker-Hopfe H; Himanen SL; Kemp B; Penzel T; Grozinger M; Kunz D; Rappelsberger P; Schlogl A; Dorffner G
    Neuropsychobiology; 2005; 51(3):115-33. PubMed ID: 15838184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a mandibular repositioning appliance on sleep structure, morning behavior and clinical symptomatology in patients with snoring and sleep-disordered breathing.
    Saletu A; Anderer P; Parapatics S; Matthai C; Matejka M; Saletu B
    Neuropsychobiology; 2007; 55(3-4):184-93. PubMed ID: 17700043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality.
    Donath F; Quispe S; Diefenbach K; Maurer A; Fietze I; Roots I
    Pharmacopsychiatry; 2000 Mar; 33(2):47-53. PubMed ID: 10761819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonorganic insomnia in panic Disorder: comparative sleep laboratory studies with normal controls and placebo-controlled trials with alprazolam.
    Saletu-Zyhlarz GM; Anderer P; Berger P; Gruber G; Oberndorfer S; Saletu B
    Hum Psychopharmacol; 2000 Jun; 15(4):241-254. PubMed ID: 12404319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise.
    Saletu B; Kindshofer G; Anderer P; Grünberger J
    Int J Clin Pharmacol Res; 1987; 7(5):407-18. PubMed ID: 2889679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality.
    Saletu B; Gruber G; Saletu M; Brandstätter N; Hauer C; Prause W; Ritter K; Saletu-Zyhlarz G
    Neuropsychobiology; 2000; 41(4):181-9. PubMed ID: 10828727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
    Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.
    Uchimura N; Nakajima T; Hayash K; Nose I; Hashizume Y; Ohyama T; Habukawa M; Kotorii N; Kuwahara H; Maeda H
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):22-9. PubMed ID: 16048734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole.
    Saletu M; Anderer P; Saletu B; Hauer C; Mandl M; Semler B; Saletu-Zyhlarz G
    Hum Psychopharmacol; 2001 Mar; 16(2):177-187. PubMed ID: 12404588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping.
    Saletu-Zyhlarz G; Saletu B; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):117-29. PubMed ID: 9313244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodic leg movements during sleep and periodic limb movement disorder in patients presenting with unexplained insomnia.
    Ferri R; Gschliesser V; Frauscher B; Poewe W; Högl B
    Clin Neurophysiol; 2009 Feb; 120(2):257-63. PubMed ID: 19109055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.